Literature DB >> 2536610

Human autoantibody to topoisomerase II.

A Hoffmann1, M M Heck, B J Bordwell, N F Rothfield, W C Earnshaw.   

Abstract

The rheumatic diseases are characterized by the production of autoantibodies that are usually directed against components of the cell nucleus. In this communication, we describe autoantibodies that recognize DNA topoisomerase II (anti-topoII) present in the serum of a patient with systemic lupus erythematosus. Several lines of evidence indicate that this antibody recognizes topoisomerase II. First, it binds to the native enzyme in soluble extracts prepared from isolated chromosomes and effectively depletes such extracts of active enzyme. Second, the serum binds to topoisomerase II in immunoblots of mitotic chromosomes and chromosome scaffolds. Finally, the antiserum binds strongly to a fusion protein encoded by a cloned cDNA and expressed in Escherichia coli that (based on immunological evidence) represents the carboxy-terminal portion of chicken topoisomerase II. Autoantibodies such as the one described here may provide useful reagents for the study of human topoisomerase II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536610     DOI: 10.1016/0014-4827(89)90067-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35.

Authors:  B Grigolo; I Mazzetti; R Meliconi; S Bazzi; R Scorza; M Candela; A Gabrielli; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Molecular and genetic analysis of condensin function in vertebrate cells.

Authors:  Damien F Hudson; Shinya Ohta; Tina Freisinger; Fiona Macisaac; Lau Sennels; Flavia Alves; Fan Lai; Alastair Kerr; Juri Rappsilber; William C Earnshaw
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

3.  Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.

Authors:  B Grigolo; I Mazzetti; R M Borzì; I D Hickson; M Fabbri; L Fasano; R Meliconi; A Facchini
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 4.  Autoantibodies to components of the mitotic apparatus.

Authors:  J B Rattner; G J Mack; M J Fritzler
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

5.  Quantitative Proteomics of the Mitotic Chromosome Scaffold Reveals the Association of BAZ1B with Chromosomal Axes.

Authors:  Shinya Ohta; Takako Taniguchi; Nobuko Sato; Mayako Hamada; Hisaaki Taniguchi; Juri Rappsilber
Journal:  Mol Cell Proteomics       Date:  2018-09-28       Impact factor: 5.911

6.  Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II.

Authors:  E R Wood; W C Earnshaw
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Analysis of human antitopoisomerase-I idiotypes.

Authors:  D Vazquez-Abad; V Pascual; M Zanetti; N F Rothfield
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Antibodies to topoisomerase II in idiopathic pulmonary fibrosis.

Authors:  R Meliconi; C Negri; R M Borzì; A Facchini; C Sturani; L Fasano; M Fabbri; G C Astaldi Ricotti
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

9.  Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis.

Authors:  K L Zuklys; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

10.  ScII: an abundant chromosome scaffold protein is a member of a family of putative ATPases with an unusual predicted tertiary structure.

Authors:  N Saitoh; I G Goldberg; E R Wood; W C Earnshaw
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.